Concepedia

Author

Edward R. Walker

Boehringer Ingelheim (United States)ORCID

Also Known As

E. Walker, EDWARD R. H. WALKER, Edward R. H. Walker, Edward R. Walker, Edward Walker

16

Publications

234

Citations

7

H-Index

19

Concepts

All Affiliations

Boehringer Ingelheim (United States)Evotec (United Kingdom)Evotec (Germany)Boehringer Ingelheim (Germany)
ER

About

Edward R. Walker is an author at Boehringer Ingelheim (United States) specializing in pharmacology, drug discovery, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

92

2

Biochemistry

3

3

62

3

Engineering

1

1

42

4

Natural Sciences

1

1

27

5

Chemical Biology

1

1

27

Edward R. Walker

×

6

Publications

207

Citations

6

H-Index

YearCitations

Studies towards the total synthesis of Sch 56036; isoquinolinone synthesis and the synthesis of phenanthrenes

Edward R. Walker, Anthony G. M. Barrett

Tetrahedron Letters

2005

73

Ytterbium(III) triflate-catalysed preparation of calix[4]resorcinarenes: Lewis assisted Brønsted acidity

Anthony G. M. Barrett, D. Christopher Braddock, Julian P. Henschke,

Journal of the Chemical Society Perkin Transactions 1

1999

42

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity

Monika Ermann, Doris Riether, Edward R. Walker,

Bioorganic & Medicinal Chemistry Letters

2008

30

Some studies on peptide analogues involving the sulphinamide group

David Merricks, Peter G. Sammes, Edward R. Walker,

Journal of the Chemical Society Perkin Transactions 1

1991

27

1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability

Doris Riether, Lifen Wu, Pier F. Cirillo,

Bioorganic & Medicinal Chemistry Letters

2011

21

Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters

Renée Zindell, Edward R. Walker, John Scott,

Bioorganic & Medicinal Chemistry Letters

2011

14

Page 1